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represent an important reality of modern protein science, it is hard
to imagine now that there were times when the idea that a biolog-
ically active protein can do its important biological job(s) in the
absence of a unique structure was taken as a heresy. In fact, just
mere decade and a half ago, a person interested in learning about
biological functions of such structure-less proteins would be
engaged in a long, tedious, and laborious treasure hunt digging
through the piles of scientific publications in a hope to uncover a
pearl. The situation is changed now due to the efforts of pioneers
(groups of Peter Wright, Vladimir Uversky, Keith Dunker, and Peter
Tompa) and numerous research groups all over the word that have
made significant contributions to the advances made in the field.
As a result, the convincing evidence is generated that clearly shows
that the intrinsic disorder cannot be ignored anymore since it is
here, there, and everywhere.
To the first look, an intrinsically disordered protein (IDPs) or an
intrinsically disordered protein region (IDPR) has to be simpler
than their structured counterparts, since such structure-less entity
clearly lacks some physical means determining the ability of a
polypeptide chain to fold spontaneously. However, nothing is sim-
ple about disordered proteins. For example, IDPs/IDPRs are struc-
turally heterogeneous and contain different combinations of
foldons (independent foldable units of a protein), inducible foldons
(disordered regions that can fold at least in part due to the interac-
tion with binding partners), non-foldons (non-foldable protein
regions), semi-foldons (regions which are always in semi-folded
state), and unfoldons (regions that undergo order-to-disorder tran-
sition to become functional). This structural heterogeneity defines
the pleiotropy of functions ascribed to IDPs and IDPRs, which may
arise from a specific disordered form, from inter-conversion
between disordered forms, and from transitions between disor-
dered to ordered or ordered to disordered states. Therefore, a very
difficult task of predicting biological function from the crystal
structure of an ordered protein is converted for an IDP into the pro-
cess of wild guessing of what this protein cloud or bowl of noodles
can do.
Functionally, the lack of structure in a protein or its part could
be as important as the presence of precisely fixed structure in the
catalytic site of an enzyme. The biological importance of protein
pliability is supported by the evolutionary persistence of IDPs/
IDPRs, by the natural abundance of IDPs/IDPRs in any known pro-
teome, and by the unique set of functions associated with disor-
dered proteins and regions. Functional repertoires of ordered anddisordered proteins are complementary, with IDPs/IDPRs being
able to do things which were not even imagined when the universe
of functional proteins was considered to be rigid. Being promiscu-
ous binders, IDPs/IDPRs are constantly involved in various interac-
tions, are able to different fold at interaction with diverse partners,
and are known to play key roles in protein–protein interaction
networks.
Obviously, disorder is not only present in the stand-alone IDPs,
but plays a number of important roles in protein complexes. Here,
in addition to the external uses (where the pliability is used by a
complex to communicate with some specific external regulators),
intrinsic disorder in protein complexes has a number of internal
applications, which range from the specific roles in complex
assembly, to the controlled movement of complex parts, and to
the diverse functional regulations and adjustments. Being able to
fold to a specific structure on a template-dependent manner, some
IDPRs serve as the molecular glue or mortar that cements impor-
tant parts of protein complexes. Other IDPRs utilize their ability
to be engaged in the entropic chain activities, preserving pliability
even in their bound states and thereby acting as highly flexible
scaffolds or crucial constituents of stochastic machines and
binding rheostats. Still other IDPRs define the ability of a protein
complex to be involved in polyvalent interactions. Finally, intrinsic
disorder plays a role in determining the order of a complex assem-
bly and has numerous functional applications based on the utiliza-
tion of entropic activities of non-foldons, induced folding of
foldons, and induced functional unfolding of unfoldons.
Remarkably, the aforementioned various roles of intrinsic disor-
der ascribed to the IDPRs of protein complexes can be found within
one protein. This idea is illustrated by Fig. 1 and cover image of this
issue that show the peculiar correlation between the intrinsic dis-
order propensity of p53 and its biological functions. Here, the
tetramerization domain of p53 serves as the molecular glue or
mortar by providing means for the p53 homo-tetramer formation.
Multiple short recognition regions located at the N- and C-terminal
regulatory domains define the polyvalent interactability of this
protein, whereas the disordered linker regions connecting func-
tional domains and binding regions of p53 provide an example of
the entropic chain activities.
This Special Issue is dedicated to the representation of some
intriguing aspects of dynamics, flexibility, and intrinsic disorder
in protein assemblies. It attempts to inform and encourage protein
researchers to think about the omnipresence of intrinsic disorder
and its fascinating biology.
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Fig. 1. Comparison of intrinsic disorder and molecular interactions of tumor suppressor p53. The PONDR FIT meta-prediction of intrinsic disorder for p53 is shown (center,
black line) along with plus and minus one average error among component predictors (grey area). Predictions above 0.5 are indicative of intrinsic disorder and below 0.5 are
indicative of intrinsic structure. The regions of p53 for which there are known complex structures are highlighted regions of the sequence (colored boxes) and corresponding
structures are indicated (grey arrows). At least 20 bound p53 structures are known, which include the N-terminal tail, C-terminal tail, and DNA binding domain (DBD).
Renderings of the complexes between p53 (various colored ribbons) and various partners (blue surfaces) are shown (the PDB identifiers of theses complexes are given in
parenthesis below). For the N-terminal tail, 7 bound structures are shown (clockwise from lower left): TAZ2 domain of p300 bound to two different regions (2MZD and 2K8F),
HMGB1 (2LY4), CBP NCB domain (2L14), MDM2 (1YCR), TFIIH (2RUK), RPA70 (2B3G). For the C-terminal tail, 8 bound structures are shown (clockwise from upper left): tGnc5
(1Q2D), the p53 tetramerization domain (3SAK), SET9 (1XQH), cyclin A (1H26), sirtuin (1MA3), CBP bromo domain (1JSP), S100bb (1DT7), 53BP1 tudor domain (2MWO). For
the DBD, 5 bound structures are shown (right to left): sv40 LTA (2H1L), BCL-xL (2MEJ), 53BP2 (1YCS), 53BP1 BRCT domains (1GZH), DNA (3KMD).
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